Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $67.99 | $6.80/mg | In stock | Jul 8 |
| vial | 20mg | $117.99 | $5.90/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. Tesamorelin is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Glacier Aminos sell Tesamorelin?
Yes — Glacier Aminos currently lists Tesamorelin in 2 variants starting at $117.99 ($5.90/mg).
Is Glacier Aminos's Tesamorelin third-party tested?
Yes — Disclosed Labs has indexed 10 Certificates of Analysis for Glacier Aminos's Tesamorelin, with the most recent showing 99.8% purity. Glacier Aminos holds an overall trust grade of A (96/100) across all 194 COAs on file.
What is Glacier Aminos's trust grade for Tesamorelin?
Glacier Aminos has an overall Disclosed Labs trust grade of A (96/100), computed from 194 COAs across all peptides. The most recent Tesamorelin COA was issued by ILS Labs.
Where is the cheapest Tesamorelin?
As of the latest data, Peptide Supply Co. offers Tesamorelin at $3.50/mg — compare with Glacier Aminos's listing at $5.90/mg. See the full Tesamorelin price comparison.
Is Tesamorelin legal to buy?
Tesamorelin is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| TES10GA-06 | Apr 2026 | 99.9% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |
| TES20GA-03 | Mar 2026 | 99.9% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Confirmed | View |
| TES10GA03 | Dec 2025 | 99.5% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| TES10GA02 | Oct 2025 | 99.8% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| TES1092501 | Sep 2025 | — | Forever Young Pharmacy | Endotoxin | Unverified | View |
| TES10GA04 | — | 99.3% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| TES20GA01 | — | 99.7% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| TES20GA02 | — | 99.4% | Freedom Diagnostics | Endotoxin | Confirmed | View |
| TES10GA-05 | — | 98.6% | Freedom Diagnostics | Endotoxin | Confirmed | View |